StockData
Mesa Laboratories Inc logo

Mesa Laboratories Inc (MLAB) company profile

MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3074% above fair value
$139.01+3.81 (+2.82%)

Close on Nov 13, 2026Market cap $777.88MP/E 120.9Yield 0.46%

About Mesa Laboratories

Industrial Instruments For Measurement, Display, and Control, SIC 3823

Mesa Laboratories, Inc. designs and manufactures life sciences tools and quality control solutions for regulated applications. The company operates through four primary divisions: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Its product offerings encompass biological and chemical indicators, genetic analysis instruments, automated systems for protein analysis and peptide synthesis, continuous monitoring systems, and calibration instruments. Mesa also provides maintenance, testing, and calibration services. It serves customers in the pharmaceutical, healthcare, medical device, dental, and academic sectors.

The company conducts manufacturing operations across facilities in the United States and Europe, including sites in Colorado, Montana, California, Arizona, Germany, and Sweden. Mesa distributes products globally through direct sales personnel in North America, Europe, and the Asia Pacific region, as well as through independent distributors. It employs 717 individuals, including roughly 450 workers located domestically. Mesa Laboratories maintains its corporate headquarters in Lakewood, Colorado.

Summary of the business section of Mesa Laboratories's latest annual report, written by StockData.

Company profile

Company

Legal name
Mesa Laboratories Inc
Founded
1982
Headquarters
Lakewood, CO
Address
12100 W 6th Ave 80228
Phone
(303) 987-8000
Employees
717, Mar 31, 2026
Industry
Industrial Instruments For Measurement, Display, and Control
Incorporated in
Colorado
Fiscal year ends
March 31
Auditor
Baker TillyLLP, Los Angeles, California

Stock & identifiers

Ticker
MLAB
Exchange
Nasdaq
IPO date
Feb 29, 1984
Shares outstanding
6M, Aug 3, 2026
Public float
$358.00M, Sep 30, 2025
Filer category
Accelerated filer
SEC CIK
724004
CUSIP
59064R109
ISIN
US59064R1095
FIGI
BBG000BP3PW7
Share class FIGI
BBG001S5T762
LEI
549300ZCG738WLX8ZW79
EIN
84-0872291

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Sanket ShahGeneral Counsel–
Siddhartha KadiaPresident and CEO7,093
Lyndsey Elizabeth CrennenCAO2,020
Brian David ArchboldSVP Operations6,377
John SakysCFO19,835
Gary M. OwensPresident and CEO64,135
John James SullivanDirector64,528
R. Tony TripenyDirector6,298
Shiraz Shabanali LadiwalaDirector12,333
Jennifer Sadie AlltoftDirector7,662
Mark Christopher CaponeDirector6,213
Shannon HallDirector6,973

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026$6.64M$516.20K$2.33M$37$35
FY2025$6.60M$7.94M$2.28M$50$33
FY2024$5.44M$78.00K$1.78M$46$43
FY2023$5.19M-$3.60M$1.48M$72$46
FY2022$18.08M$16.81M$1.45M$105$66
FY2021$2.56M$9.55M$927.47K$108$169

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2026

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Gary Owens
Former CEO and President
$808.85K$4.70M$1.12M$14.35K$6.64M+1%
John Sakys
VP and Chief Financial Officer
$498.39K$1.55M$408.75K$14.26K$2.47M+2%
Brian Archbold
SVP of Operations and Continuous Improvement
$436.96K$1.40M$331.25K$14.23K$2.18M+2%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of March 31, 2026, we had 717 employees (including approximately 450 domestic employees), of whom 347 are employed for manufacturing and quality assurance, 99 for research and development and engineering, 179 for sales and marketing, and 92 for administrative functions.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?